Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,423 INR | +0.57% | -3.47% | -0.62% |
04-29 | Jefferies Adjusts SBI Life Insurance’s Price Target to INR1,740 From INR1,700, Keeps at Buy | MT |
04-29 | Nomura Adjusts SBI Life Insurance’s Price Target to INR1,750 From INR1,700, Keeps at Buy | MT |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
Weaknesses
- The company has insufficient levels of profitability.
- With an expected P/E ratio at 73.86 and 66.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.62% | 16.99B | C+ | ||
+4.42% | 95.15B | B | ||
+4.15% | 94.71B | B- | ||
-15.80% | 77.24B | B+ | ||
+17.74% | 74.93B | D+ | ||
+11.65% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
+7.10% | 26.97B | A | ||
-11.07% | 15.16B | B | ||
+21.82% | 12.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBILIFE Stock
- SBILIFE Stock
- Ratings SBI Life Insurance Company Limited